Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Pepaxti

Pepaxti 20 mg powder for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 8

HOS-148669 · Präparat HOS-099940

Respiratory, thoracic Pulmonary Uncommon Uncommon and mediastinal embolism disorders Dyspnoea Very common Uncommon Dyspnoea exertional Common - Cough Very common Uncommon Epistaxis Common Uncommon Gastrointestinal Diarrhoea Very common Common disorders Nausea Very common Uncommon Vomiting Common Uncommon General disorders and Pyrexia Very common Common administration site Fatigue Very common Common conditions Asthenia Very common Common 1 Sepsis includes the events sepsis, escherichia sepsis, bacterial sepsis, and urosepsis 2 Pneumonia includes the events pneumonia, pneumocystis jirovecii pneumonia, COVID-19 pneumonia, Pneumonia influenzal, and pneumonia viral 3 Respiratory tract infection includes the events respiratory tract infection, respiratory tract infection viral, upper respiratory tract infection, viral upper respiratory tract infection, bronchitis, bronchitis viral, and lower respiratory tract infection 4 Thrombocytopenia includes the events thrombocytopenia and platelet count decreased 5 Neutropenia includes the events neutropenia and neutrophil count decreased

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.